| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.079.776 | 8.489.370 | 6.873.078 | 6.975.748 | 7.778.565 | 6.121.777 | 6.731.671 | 6.573.649 | 10.278.657 | 11.026.428 |
| Total Income - EUR | 9.278.814 | 8.574.442 | 6.920.519 | 7.024.485 | 7.864.753 | 6.218.653 | 6.811.227 | 6.739.619 | 10.482.476 | 11.096.301 |
| Total Expenses - EUR | 7.476.115 | 7.020.729 | 5.949.519 | 5.995.259 | 6.599.488 | 5.507.753 | 5.939.355 | 6.042.635 | 8.477.871 | 9.134.655 |
| Gross Profit/Loss - EUR | 1.802.699 | 1.553.712 | 971.000 | 1.029.225 | 1.265.266 | 710.900 | 871.872 | 696.984 | 2.004.605 | 1.961.646 |
| Net Profit/Loss - EUR | 1.518.385 | 1.334.028 | 836.129 | 881.489 | 1.070.209 | 616.434 | 749.433 | 592.834 | 1.713.960 | 1.667.547 |
| Employees | 36 | 38 | 35 | 44 | 48 | 41 | 42 | 32 | 33 | 31 |
Check the financial reports for the company - Rombiomedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 76.684 | 132.858 | 289.021 | 398.023 | 356.652 | 338.879 | 270.478 | 284.399 | 230.333 | 270.820 |
| Current Assets | 6.719.663 | 6.419.217 | 5.483.830 | 4.492.771 | 4.841.730 | 4.109.865 | 4.823.316 | 4.854.889 | 6.279.397 | 8.396.107 |
| Inventories | 977.511 | 850.918 | 1.172.590 | 1.221.269 | 1.664.920 | 1.674.352 | 1.536.859 | 2.009.844 | 1.924.957 | 2.168.142 |
| Receivables | 3.312.252 | 2.514.852 | 1.566.630 | 1.298.329 | 1.150.498 | 809.796 | 1.516.359 | 978.296 | 4.020.714 | 2.684.138 |
| Cash | 2.429.899 | 3.053.447 | 2.744.610 | 1.973.173 | 2.026.312 | 1.625.717 | 1.770.098 | 1.866.750 | 333.726 | 3.543.826 |
| Shareholders Funds | 1.586.414 | 2.904.263 | 914.442 | 960.701 | 1.147.887 | 692.639 | 823.949 | 667.581 | 1.788.480 | 1.741.650 |
| Social Capital | 461 | 456 | 449 | 441 | 432 | 424 | 414 | 416 | 414 | 412 |
| Debts | 5.212.152 | 3.649.466 | 4.859.918 | 3.893.478 | 4.020.138 | 3.750.284 | 4.281.910 | 4.480.758 | 4.753.705 | 6.954.805 |
| Income in Advance | 0 | 0 | 0 | 42.404 | 35.638 | 12.592 | 2.897 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Rombiomedica Srl